Matt serves clients within the life science industry on commercial strategy issues. He has led projects that leverage detailed and integrative analytics to inform critical strategic decisions, focused on market opportunity identification (including physician and patient segmentation), product positioning and launch strategies, and customer engagement model design. He has deep expertise in complex hematology/ oncology, immunology, and orphan disease markets, with significant experience in cardiovascular, CNS, and infectious disease markets. He has led multiple internal knowledge development initiatives for the firm, including research on state-of-the art approaches to segmentation, understanding adherence from a business perspective, and integrating clinical and access research to inform comprehensive assessments of market potential.
Matt is a guest lecturer at Harvard, MIT, and the Broad Institute. He earned his MBA from the Yale School of Management in Yale’s Healthcare MBA program and his BA in Economics from Boston College.